In Vitro and In Vivo Antiviral Studies of New Heteroannulated 1,2,3-Triazole Glycosides Targeting the Neuraminidase of Influenza A Viruses

• Egile Nagusiak: Omnia Kutkat (Egilea), Ahmed Kandeil (Egilea), Yassmin Moatasim (Egilea), Yaseen A. M. M. Elshaier (Egilea), Wael A. El-Sayed (Egilea), Samir T. Gaballah (Egilea), Ahmed El Taweel (Egilea), Mina Nabil Kamel (Egilea), Mohamed El Sayes (Egilea), Mohammed A. Ramadan (Egilea), Rabeh El-Shesheny (Egilea), Farouk M. E. Abdel-Megeid (Egilea), Richard Webby (Egilea), Ghazi Kayali (Egilea), Mohamed A. Ali (Egilea)
• Formatua: Liburua
• Argitaratua: MDPI AG, 2022-03-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

There is an urgent need to develop and synthesize new anti-influenza drugs with activity against different strains, resistance to mutations, and suitability for various populations. Herein, we tested in vitro and in vivo the antiviral activity of new 1,2,3-triazole glycosides incorporating benzimida...